Apolipoprotein E, methylenetetrahydrofolate reductase (MTHFR) mutation and the risk of senile dementia -an epidemiological study using the polymerase chain reaction (PCR) method

Journal of Epidemiology

Volumn 10, Issue 3, 2000, Pages 163-172

  Nishiyama, Midori ^a   Kato, Yukie ^a   Hashimoto, Michiyo ^a   Yukawa, Satoru ^a   Omori, Kenichi ^a  

^a DOKKYO MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); OXIDOREDUCTASE;

AGED; ALZHEIMER DISEASE; ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; CONFIDENCE INTERVAL; CROSS-SECTIONAL STUDY; FEMALE; GENE FREQUENCY; GENETICS; GENOTYPE; HEALTH SURVEY; HUMAN; JAPAN; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; MUTATION; NUCLEOTIDE SEQUENCE; PREVALENCE; RISK; STATISTICAL MODEL;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; APOLIPOPROTEINS E; BASE SEQUENCE; CONFIDENCE INTERVALS; CROSS-SECTIONAL STUDIES; FEMALE; GENE FREQUENCY; GENOTYPE; HEALTH SURVEYS; HUMANS; JAPAN; LOGISTIC MODELS; MALE; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); MIDDLE AGED; MULTIVARIATE ANALYSIS; MUTATION; ODDS RATIO; OXIDOREDUCTASES ACTING ON CH-NH GROUP DONORS; PREVALENCE;

EID: 37849186628     PISSN: 09175040     EISSN: None     Source Type: Journal    
DOI: 10.2188/jea.10.163     Document Type: Article

References (25)

1. Miyanaga K. Changes in the disease which cause dementia-comparison between Japan and the world. J Sen Dement, 1999;13:129-141 (in Japanese).
2. Tanzi RE , George-Hyslop PH, Haines JL et al. The genetic defect in familial Alzheimer's disease is not tightly linked to the amyloid beta-protein gene. Nature, 1987;329:156-157.
3. Kamino K, Orr HT, Payami H, Wijsman EM et al. Linkage and mutational analysis of familial Alzheimer disease kindreds for the APP gene region. Am J Hum Genet, 1992;51:998-1014.
4. Corder EH, Saunders AM, Strittmatter WJ, et al. Gene Dose of Apolipoprotein E Type 4 Allele and the Risk of Alzheimer's Disease in Late Onset Families. Science, 1993; 261:921-923.
5. Poirier J, Davignon J, Bouthillicr D, et al. Apolipoprotein E polymorphism and Alzheimer's disease. Lancet, 1993; 342:697-699.
6. Saunders AM, Strittmatter WJ, Schmechel D, et al. Association of apolipoprotein E alle e 4 with late-onset familial and sporadic Alzheimer's disease. Neurology, 1993;43:1467-1472.
7. Frosst P, Blom HJ, Milos R, et al. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase, Nature Genet, 1995; 10: 111-113.
8. Wilcken DEL, Wang XL, Sim AS, et al. Distribution in healthy and coronary population of the methylenetetrahydrofolate reductase (MTHFR) C677 T mutation : Arteriosclerosis, thrombosis, and Vascular Biology, 1996; 16,878-882.
9. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Third Edition, Revised. Washington, DC: American Psychiatric Association, 1987.
10. Hixson JE, Vernier DT. Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with Hhal. J. Lipid Res, 1990; 31:545-548.
11. Emi M, Wu LL, Robertoson MA, et al. Genotyping and sequence analysis of apolipoprotein E isoforms. Genomics, 1988; 3:373-379.
12. Nishio H, Lee MJ, Fujii M, et al. A common mutation in methylenetetrahydrofolate reductase gene among the Japanese population. Jpn J Human Genet, 1996; 41:247251.
13. Fomo GDF, Rasmusson DX, Brandt, et al. Apolipoprotein E genotype and rate of decline in probable Alzheimer's disease. Arch Neural. 1996;53:345-350.
14. Zannis VI, Breslow JL. Human VLDL Apo E isoprotein polymorphism is explained by genetic variation and posttranslational modification. Biochemistry, 1981; 20:10331041.
15. Breslow JL, Zannis VI, SanGiacomo TR, et al.Studies of familial type III hyperlipoproteinemia using as a genetic marker the Apo E penotype E2/2. J Lipid Res, 1982; 23: 1224-1235.
16. Boerwinkle E, Visvikis S, Welsh D, et al. The use of measured genotype information in the analysis of quantitive phenotypes in man. II. The role of the apolipoprotein E polymorphism in determing levels, variability, and covariability of cholesterol, betalipoprotein, and triglycéride in a sample of unrelated individuals. Am J Med Genet, 1989; 27:567-582.
17. Huffman A, Ott A, Breteler MMB, et al. Atherosclerosis, apolipoprotein E, and prevalance of dementia and Alzheimer's disease in the Rotterdam study. Lancet, 1997; 349:151-154.
18. Okuizumi K. Genetic association of very low density lipoprotein (VLDL) receptor gene with sporadic Alzheimer's disease, Nature Genet. 1995; 11:207.
19. Kang SS, Worig PWK, Susmano A, et al. Thermolabile methylenetetrahydrofolate reductase: An inherited risk factor for coronary artery disease. Am J Hum Genet, 1991;48,536-545.
20. Anderson JL, King GJ, Thomson MJ, et al. A mutation in the methylentetrahydrofolate reductase gene is not associated \vith increased risk for coronary artery disease or myocardial infarction. Am Colleg Cardiol, 1997 ;30:12061211.
21. Cattaneo M, Tsai MY, Bucciarelli P, Taiolo E, et al. A commom mutation in the methylenetetrahydrofolate reductase gene (C677T) increase the risk for deep-vein thrombosis in patients with mutant factor V (Factor VrQ506). Atrerioscler Thromb Vase Biol. 1997; 17:1662-1666.
22. Rccs DC, Liu YT, Cox MJ, et al.Factor V Leiden and thermolabile methylenetetrahydofolate reductase in extreme old age. Thromb Haemost, 1997; 78:1357-1359.
23. Yoshitake T, Kiyohara Y, Kato I, et al. Incidence and risk factors of vascular dementia and Alzheimer's disease in a defined elderly Japanese population:The Hisayama Study. Neurology, 1995; 45: 1161-1168.
24. Deloughery TG, Evans A, Sadeghi A, et al. Common mutation in Methylenetetrahydrofolate reductase. Correlation with Homocysteine metabolism and lateoncet vascular disease. Circulation, 1996;94:3074-3078.
25. White L, Petrovitch H, ROSS W, et al. Prevalence of dementia in older Japanese-American Men in Hawaii. The Honolulu-Asia aging study. J Am Med Association, 1996;276(12):955-960.